SCHEMBL31428569

SCHEMBL31428569

CC(=O)N1/C(=C\c2cc(-c3ccc(-c4ccccc4)cc3)c3cc(C(=O)O)ccc3n2)C(=O)c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HTT P42858 2/20 0.44
MAPT P10636 2/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CES1 P23141 1/20 0.39
IP6K1 Q92551 3/20 0.39
IP6K3 Q96PC2 3/20 0.39
IP6K2 Q9UHH9 3/20 0.39
RAB9A P51151 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PKM P14618 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
KDM4E B2RXH2 3/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31428957 0.94 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428638 0.94 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428736 0.92 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428878 0.88 MAPT (0.44) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428814 0.87 MAPK1 (0.43) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428624 0.86 PDCD1 (0.48) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428789 0.86 PDCD1 (0.46) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428974 0.84 MAPT (0.41) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428782 0.84 PDCD1 (0.49) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428528 0.84 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2HTTMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS ALDH1A1 2352/4885SMN1; SMN2 4832/4885HTT 4442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.